Records containing: Non-muscle Invasive Bladder Cancer (NMIBC)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-21Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
-
CLINICAL_TRIALS study record update · 2025-10-16Phase 2 Clinical Trial of Ablation Therapy With Intravesical N-803 In Combination With BCG or Gemcitabine in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer
-
CLINICAL_TRIALS study record update · 2025-09-22Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
-
CLINICAL_TRIALS study record update · 2025-08-14A Phase I/II, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Intravesical FL115 Alone or in Combination With BCG in Subjects With Non-Muscle Invasive Bladder Cancer, Including Dose Escalation and Cohort Expansion
-
CLINICAL_TRIALS study record update · 2023-10-13Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-10-05Intravesical Hyaluronic Acid Sodium Salt and Hydeal-D for Relief of Storage Lower Urinary Tract Symptoms (LUTS) After Trans-urethral Resection of Bladder Tumor (TURBT) for Non-muscle Invasive Bladder Cancer (NMIBC). Monocentric, Randomized, Controlled Investigation.
-
CLINICAL_TRIALS study record update · 2022-05-11Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors
-
CLINICAL_TRIALS study record update · 2021-06-08A Combined Phase 1 and Phase 2 Study of Albumin-bound Rapamycin Nanoparticles (Nab-rapamycin, ABI-009) in the Treatment of BCG Refractory or Recurrent Nonmuscle Invasive Transitional Cell Bladder Cancer
-
CLINICAL_TRIALS study record update · 2020-08-19A Phase 2 Study of BC-819 in Patients With Non-Muscle Invasive Bladder Cancer Whose Disease is Unresponsive to Bacillus Calmette-Guerin
-
CLINICAL_TRIALS study record update · 2020-07-31A Parallel Group Phase I/II Marker Lesion Study to Assess the Safety, Tolerability and Efficacy of Intravenous or Intravesical Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer
-
CLINICAL_TRIALS study record update · 2018-01-09Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident